Keystone Symposia – 2025 – Poster Presentation 2033 […]
Publication Type: Poster Presentation
Understanding the Patient Experience and Potential Barriers to Enrollment and Participation in Cell and Gene Therapy (CGT) Trials in Acute Myeloid Leukemia (AML)
Tandem Meetings – 2025 – Poster Presentation 503 […]
A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)
ASH – 2024 – Poster Presentation 2873 […]
Multimodal atlas of paired diagnosis and relapse AML reveals surface antigens for multi-specific immunotherapy
ASH – 2024 – Poster Presentation 1558 […]
Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to treat AML
SITC – 2024 – Poster Presentation 1092 […]
Read More… from Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to treat AML
Purification of CAR+ T Cells Reveals Impact of Untransduced Cells in CAR-T Drug Product
Immuno-Oncology Summit – 2024 – Poster Presentation P26 […]
Deploying a CD45-Antibody Drug Conjugate for Allogeneic Hematopoietic Stem Cell Transplant in Non-Human Primates
ASTCT-EBMT – 2024 – Poster Presentation […]
Gene-Edited Hematopoietic Stem Cells to Enable Next-Generation CAR-T Cell Therapy for the Treatment of AML
ASGCT – 2024 – Poster Presentation 1775 […]
Uncovering Molecular and Functional Dynamics of Human Hematopoietic Stem Cells during In Vitro Culture for Cell Therapy Manufacturing
Keystone Symposia – 2024 – Poster Presentation 1040 […]